
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10782921
[patent_doc_number] => 20160129077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma'
[patent_app_type] => utility
[patent_app_number] => 14/907263
[patent_app_country] => US
[patent_app_date] => 2014-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7107
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/907263 | Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma | Jun 12, 2014 | Abandoned |
Array
(
[id] => 10776233
[patent_doc_number] => 20160122389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4'
[patent_app_type] => utility
[patent_app_number] => 14/896249
[patent_app_country] => US
[patent_app_date] => 2014-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9865
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896249
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896249 | Peptides with antagonistic activities against natural CXCR4 | Jun 11, 2014 | Issued |
Array
(
[id] => 14360683
[patent_doc_number] => 10301629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
[patent_app_type] => utility
[patent_app_number] => 14/897450
[patent_app_country] => US
[patent_app_date] => 2014-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 39069
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/897450 | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides | Jun 10, 2014 | Issued |
Array
(
[id] => 11053371
[patent_doc_number] => 20160250333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'SUBCUTANEOUS INJECTION PREPARATION FOR INDUCING BOVINE SUPEROVULATION'
[patent_app_type] => utility
[patent_app_number] => 14/907165
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4463
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907165
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/907165 | Subcutaneous injection product for cattle for inducing superovulation | May 22, 2014 | Issued |
Array
(
[id] => 9720934
[patent_doc_number] => 20140256634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Treatments for Gastrointestinal Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/286145
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16070
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/286145 | Treatments for Gastrointestinal Disorders | May 22, 2014 | Abandoned |
Array
(
[id] => 10729616
[patent_doc_number] => 20160075765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'MODIFIED COLLAGEN MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/890037
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14616
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/890037 | MODIFIED COLLAGEN MOLECULES | May 8, 2014 | Abandoned |
Array
(
[id] => 9838538
[patent_doc_number] => 20150030618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/269577
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 122648
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/269577 | NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF | May 4, 2014 | Abandoned |
Array
(
[id] => 12165328
[patent_doc_number] => 09884087
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-02-06
[patent_title] => 'Compositions and methods of improved wound healing'
[patent_app_type] => utility
[patent_app_number] => 14/270193
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7586
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/270193 | Compositions and methods of improved wound healing | May 4, 2014 | Issued |
Array
(
[id] => 9670449
[patent_doc_number] => 20140234311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'ALBUMIN VARIANTS'
[patent_app_type] => utility
[patent_app_number] => 14/262244
[patent_app_country] => US
[patent_app_date] => 2014-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 28935
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14262244
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/262244 | ALBUMIN VARIANTS | Apr 24, 2014 | Abandoned |
Array
(
[id] => 11857955
[patent_doc_number] => 09737622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Compounds modulators of VEGF activity and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/259085
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7377
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259085
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259085 | Compounds modulators of VEGF activity and uses thereof | Apr 21, 2014 | Issued |
Array
(
[id] => 11230974
[patent_doc_number] => 09458194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 14/783689
[patent_app_country] => US
[patent_app_date] => 2014-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23621
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783689 | Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions | Apr 14, 2014 | Issued |
Array
(
[id] => 9910235
[patent_doc_number] => 20150065437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'AROMATIC-CATIONIC PEPTIDES AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 14/220974
[patent_app_country] => US
[patent_app_date] => 2014-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 17622
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220974
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/220974 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | Mar 19, 2014 | Abandoned |
Array
(
[id] => 9757565
[patent_doc_number] => 20140288266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'Synthesis of Cyclosporin Analogs'
[patent_app_type] => utility
[patent_app_number] => 14/217827
[patent_app_country] => US
[patent_app_date] => 2014-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26995
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14217827
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/217827 | Synthesis of Cyclosporin Analogs | Mar 17, 2014 | Abandoned |
Array
(
[id] => 14391311
[patent_doc_number] => 10308926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Stablized EZH2 peptides
[patent_app_type] => utility
[patent_app_number] => 14/772143
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 50
[patent_no_of_words] => 20747
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772143
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772143 | Stablized EZH2 peptides | Mar 12, 2014 | Issued |
Array
(
[id] => 13127467
[patent_doc_number] => 10081654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Stapled and stitched polypeptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/775315
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 41616
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775315 | Stapled and stitched polypeptides and uses thereof | Mar 12, 2014 | Issued |
Array
(
[id] => 11907055
[patent_doc_number] => 09775853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Hemostatic compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 14/209887
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5303
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209887
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/209887 | Hemostatic compositions and methods | Mar 12, 2014 | Issued |
Array
(
[id] => 11814917
[patent_doc_number] => 09718858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Tunable control of protein degradation in synthetic and endogenous bacterial systems'
[patent_app_type] => utility
[patent_app_number] => 14/773937
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 43
[patent_no_of_words] => 41062
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773937
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773937 | Tunable control of protein degradation in synthetic and endogenous bacterial systems | Mar 12, 2014 | Issued |
Array
(
[id] => 10938985
[patent_doc_number] => 20140342006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'Methods for Preparing Injectable Protein Microparticle Suspensions'
[patent_app_type] => utility
[patent_app_number] => 14/209350
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2613
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/209350 | Methods for Preparing Injectable Protein Microparticle Suspensions | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10649380
[patent_doc_number] => 09365616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Use of endostatin peptides for the treatment of fibrosis'
[patent_app_type] => utility
[patent_app_number] => 14/207246
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 34
[patent_no_of_words] => 24691
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14207246
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/207246 | Use of endostatin peptides for the treatment of fibrosis | Mar 11, 2014 | Issued |
Array
(
[id] => 10122499
[patent_doc_number] => 09156850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Enediyne compounds, conjugates thereof, and uses and methods therefor'
[patent_app_type] => utility
[patent_app_number] => 14/203118
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 18992
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14203118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/203118 | Enediyne compounds, conjugates thereof, and uses and methods therefor | Mar 9, 2014 | Issued |